Ignite Creation Date:
2024-05-06 @ 6:34 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05718323
Status:
RECRUITING
Last Update Posted:
2024-07-05
First Post:
2023-01-30
Brief Title:
Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive Extensive-disease SCLC
Sponsor:
ETOP IBCSG Partners Foundation
Organization:
ETOP IBCSG Partners Foundation
Organization Data
Organization:
ETOP IBCSG Partners Foundation
Class:
NETWORK
Study ID:
ETOP 23-22
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
ETOP IBCSG Partners Foundation
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| GlaxoSmithKline | INDUSTRY |
| Development Limited | UNKNOWN |